Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avanafil in erectile dysfunction
NCT00903981Phase 3Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Mar 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of avanafil in erectile dysfunction (ED) (3 arms), sponsored by JW Pharmaceutical Corporation. Primary endpoint: International Index of Erectile Function - Erectile Function domain at 12 weeks. Started Mar 2009; status: completed.
02
Drugs
avanafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00903981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903981.